Annual Meetings

   

HOME

MISSION

MEMBERSHIP

ANNUAL MEETINGS

CME/CE INFORMATION
LINKS

ALLERGY/ASTHMA
INFORMATION TOPICS

LASAACI BOARD

LASAACI MEMBERS

CONTACT US

Fall Symposium 2015

Management of Patients with Multiple Drug Allergies
Aleena Banerji, MD
Harvard Medical School
Massachusetts General Hospital

New Treatment Modalities for Atopic Dermatitis
Mark Boguniewicz, MD
National Jewish Medical and Research Center

Role of Infection in Severe Asthmatics
James Gern, MD
University of Wisconsin, Madison

New Advances in the Treatment of Food Allergies
Anna Nowak-Wegrzyn, MD
Mount Sinai Hospital and Medical Center

Left to right: Mark Boguniewicz, MD, Margaret Kurohara, MD, LASAACI President, Anna Nowak-Wegrzyn, MD,
Aleena Banerji, MD, and James Gern, MD

Many thanks to the pharmaceutical and medical companies that sponsored the Symposium:

Merck provided an Educational Grant.

Exhibitors:
Abbott Laboratories, Accredo Health Inc., Aerocrine, Inc., Alcon Laboratories, Inc., AstraZeneca LP, Baxalta Bioscience, Bio Products Laboratory (BPL), Boehringer-Ingelheim, Boston Scientific, Coram, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Grifols Bioscience, Horizon Pharma, IV League Pharmacy, Jubilant Hollister-Stier, Lincoln Diagnostics, Inc., Meda Pharmaceuticals, Merck, Mylan Specialty, Novartis Pharmaceuticals, Novartis (Inflammatory Disease Division), NuFactor/FFF Enterprises, PuraCap, Rabbit Air, Sanofi, Shire (Specialty Pharmaceuticals), Shire (Rare Diseases Unit), Soleo, TEVA Pharmaceuticals, and Walgreens Infusion Services.

 
 
 

2016 All Rights Reserved to LASAACI.
website by PM&E